Business
IceCure Medical Expands Distribution of ProSense® into Portugal Through Agreement with Medicinália Cormédica: Upfront Systems & Probes Sales
ProSense has CE mark of regulatory approval in the European UnionInitial purchase of 2 ProSense Systems plus disposable cryoprobes and introducers CAESAREA,
About this update from Icecure Medical Ltd.
[{"type":"text","content":"ProSense has CE mark of regulatory approval in the European UnionInitial purchase of 2 ProSense Systems plus disposable cryoprobes and introducers CAESAREA, Israel, July 17, 2023 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) (\"IceCure\" or the \"Company\"), developer of minimally-invasive cryoablation technology, the ProSense® System, that destroys tumors by freezing as an alternative to surgical tumor removal, today announced it has entered a non-exclusive distribution agreement with Medicinália Cormédica – MC Medical, Lda. (\"MC Medical\"), the largest distributor of third-party medical devices in Portugal and a subsidiary of Barcelona, Spain based Werfen, S.A., a world leader in specialized diagnostics operating in 30 countries. Another Werfen, S.A. company, Izasa Scientific, is a ProSense distributor in Spain. This agreement with MC Medical further expands the distribution of ProSense in Europe where the system has the European Union's CE mark of regulatory approval. \n \n \nInitial purchases by MC Medical include two ProSense consoles, along with disposable cryoprobes and introducers. Healthcare professionals in Portugal will now be able to perform precise and minimally invasive cryoablation procedures for indications including malignant and benign tissue of the breast, kidney, liver, lung, and bone, as well as for palliative interventions.\n\"We are very pleased to partner with MC Medical to expand the availability of ProSense cryoablation into Portugal,\" stated Eyal Shamir, CEO of IceCure Medical. \"Their dedication to quality and innovation in healthcare aligns with our aim to improve patient outcomes through minimally invasive cryoablation procedures. As the largest distributor of third-party medical devices in Portugal with a staff of 72 professionals across sales, service and support, MC Medical is extremely well equipped to drive ProSense adoption throughout Portugal.\"\n\"There is a growing interest in minimally invasive cryoablation procedures in Portugal driven by favorable patient outcomes and healthcare economics. IceCure's ProSense is the best choice for cryoablation systems on the market today. Backed by clinical data and regulatory approvals, ProSense is a system that we believe will gain rapid and wide market traction in Portugal,\" said Diogo Lima, General Manager of MC Medical.\nAbout ...